Figures & data
Figure 1. Accrual and selection from the outpatient clinic program of the 116 participating recurrence free patients treated for cancer of the pharynx, larynx and oral cavity.
![Figure 1. Accrual and selection from the outpatient clinic program of the 116 participating recurrence free patients treated for cancer of the pharynx, larynx and oral cavity.](/cms/asset/45e0f611-56e3-4ec8-8870-d7493f023ab3/ionc_a_141736_f0001_b.jpg)
Table I. Characteristics of the 116 recurrence free head and neck cancer patients who returned a valid questionnaire. Percentages are of the groups within one treatment modality if nothing else is stated.
Table II. Overall mean score of EORTC C30 and H&N35 and mean score dependent on site and treatment among 116 recurrence free head and neck cancer patients.
Table III. Correlation coefficient between scales of EORTC C30 and H&N35 among 116 recurrence free head and neck cancer patients.
Table IV. Internal Consistency of the multi item scales of EORTC C30 and H&N35 among 116 recurrence free head and neck cancer patients.
Figure 2. Mean scores of issues from the EORTC C30 and H&N35 significantly dependent on tumour site in 83 patients after radiotherapy for cancer of the pharynx, larynx and oral cavity. “{”Indicate significant differences between single groups with post hoc testing correcting for multiple testing.
![Figure 2. Mean scores of issues from the EORTC C30 and H&N35 significantly dependent on tumour site in 83 patients after radiotherapy for cancer of the pharynx, larynx and oral cavity. “{”Indicate significant differences between single groups with post hoc testing correcting for multiple testing.](/cms/asset/76dc8db2-8585-4253-af8e-dd1bafc4807f/ionc_a_141736_f0002_b.jpg)
Figure 3. Mean score of issues of EORTC C30 and H&N35 that were significantly dependent on tumour site in 45 stage I-II patients after radiotherapy for cancer of the pharynx, larynx and oral cavity. “{”Indicate significant differences between single groups with post hoc testing correcting for multiple testing.
![Figure 3. Mean score of issues of EORTC C30 and H&N35 that were significantly dependent on tumour site in 45 stage I-II patients after radiotherapy for cancer of the pharynx, larynx and oral cavity. “{”Indicate significant differences between single groups with post hoc testing correcting for multiple testing.](/cms/asset/a3abc544-33ed-4684-a2fd-908e7d3d7e3d/ionc_a_141736_f0003_b.jpg)